Skip to content
Research/Gene Therapy/AAV9-Follistatin Gene Therapy

AAV9-Follistatin Gene Therapy

AAV9-Follistatin gene therapy involves using an adeno-associated virus (AAV9) vector to deliver the follistatin gene into cells. Follistatin is a protein that inhibits myostatin, a growth factor that limits muscle growth. This therapy aims to enhance muscle mass and strength, which could be beneficial for age-related muscle loss and other muscle-wasting conditions, contributing to improved longevity and healthspan.

Intelligence Profile

Science

Currently, there is insufficient evidence provided specifically about the AAV9-Follistatin Gene Therapy to describe its mechanism of action. No relevant studies or data directly address how this gene therapy works at a molecular or physiological level.

For detailed clinical decisions, it’s important to consult additional specialized publications or clinical trial results specific to AAV9-Follistatin.

Disclaimer: This information is not intended to serve as medical advice. For personal health concerns, please consult a healthcare professional.